Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 12, Issue 4, Pages 1630
Publisher
MDPI AG
Online
2023-02-20
DOI
10.3390/jcm12041630
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG
- (2022) Chihiro Ishiwatari-Ogata et al. Frontiers in Immunology
- Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
- (2022) Simeng Lin et al. GUT
- Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
- (2022) Mehdi Arbabi-Ghahroudi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of ADAM17 in Inflammation-Related Atherosclerosis
- (2022) Bai-Yi Tang et al. Journal of Cardiovascular Translational Research
- Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases
- (2022) Emmanuel Moyse et al. Frontiers in Aging Neuroscience
- Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring
- (2022) Hieronymus T W Smeele et al. ANNALS OF THE RHEUMATIC DISEASES
- Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4+Foxp3+ regulatory T cells
- (2022) Tianzhen He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
- (2022) Ruben J. Boado Pharmaceutics
- The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis
- (2022) Cong Dai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
- (2022) Weijun Ou et al. Pharmaceutics
- Ozoralizumab: First Approval
- (2022) Susan J. Keam DRUGS
- Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms
- (2021) Maria Sofia Basile et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TNFR2 expression is a hallmark of human memory B cells with suppressive function
- (2021) Olga Ticha et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TNF in the era of immune checkpoint inhibitors: friend or foe?
- (2021) Allen Y. Chen et al. Nature Reviews Rheumatology
- Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study
- (2021) Shinsuke Hidese et al. Frontiers in Pharmacology
- Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road
- (2021) Asmaa Beltagy et al. Frontiers in Pharmacology
- Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
- (2021) Miquéias Lopes-Pacheco et al. Frontiers in Physiology
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry
- (2021) Ryan C. Ungaro et al. GASTROENTEROLOGY
- Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis
- (2021) Jagannadha Avasarala et al. Multiple Sclerosis and Related Disorders
- Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study
- (2021) Sudhir Karthikeyan et al. BRAIN BEHAVIOR AND IMMUNITY
- The blood–brain barrier in systemic infection and inflammation
- (2021) Ian Galea Cellular & Molecular Immunology
- Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
- (2021) Hadar Edelman-Klapper et al. GASTROENTEROLOGY
- Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
- (2021) Nicholas E Burr et al. GUT
- Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
- (2021) Weijun Ou et al. Journal of Neuroinflammation
- Secondary Mania induced by TNF ‐α inhibitors: A systematic review
- (2021) Alessandro Miola et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis
- (2021) Ju Li et al. Frontiers in Pharmacology
- Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
- (2021) Siddharth Singh et al. Lancet Gastroenterology & Hepatology
- Immunogenicity of TNF-Inhibitors
- (2020) Sadaf Atiqi et al. Frontiers in Immunology
- Neuroinflammatory events after anti-TNFα therapy
- (2020) Evripidis Kaltsonoudis et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors
- (2020) Caterina Bodio et al. AUTOIMMUNITY REVIEWS
- Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
- (2020) Yena Lee et al. BRAIN BEHAVIOR AND IMMUNITY
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
- (2020) Ruben J Colman et al. INFLAMMATORY BOWEL DISEASES
- Systemic TNF-α blockade attenuates anxiety and depressive-like behaviors in db/db mice through downregulation of inflammatory signaling in peripheral immune cells
- (2020) Musaad A. Alshammari et al. SAUDI PHARMACEUTICAL JOURNAL
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events
- (2020) Amy Kunchok et al. JAMA Neurology
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- De novo Anti-TNF-α-induced Congestive Heart Failure in a Patient With Turner Syndrome and Crohn’s Disease
- (2020) Eoin Keating et al. INFLAMMATORY BOWEL DISEASES
- Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
- (2020) Benjamin T Bradley et al. LANCET
- The Bidirectional Relationship of Depression and Inflammation: Double Trouble
- (2020) Eléonore Beurel et al. NEURON
- Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
- (2020) Yunwei Hu et al. Frontiers in Pharmacology
- Interaction of Microglia and Astrocytes in the Neurovascular Unit
- (2020) Li-rong Liu et al. Frontiers in Immunology
- Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention
- (2020) Noel Torres-Acosta et al. JOURNAL OF ALZHEIMERS DISEASE
- TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review
- (2020) Marie Muller et al. Journal of Crohns & Colitis
- Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression
- (2020) Rodrigo B. Mansur et al. PSYCHONEUROENDOCRINOLOGY
- Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder
- (2020) Rajesh Das et al. PSYCHIATRY RESEARCH
- Effects of infliximab on brain neurochemistry of adults with bipolar depression
- (2020) Rodrigo B. Mansur et al. JOURNAL OF AFFECTIVE DISORDERS
- Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study
- (2020) Jonas A. Adalsteinsson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
- (2019) Laurent Arnaud et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
- (2019) Roger S. McIntyre et al. JAMA Psychiatry
- Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
- (2019) Daniela Enache et al. BRAIN BEHAVIOR AND IMMUNITY
- Considerations for the Design of Antibody-Based Therapeutics
- (2019) Dennis R. Goulet et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanobody approval gives domain antibodies a boost
- (2019) Chris Morrison NATURE REVIEWS DRUG DISCOVERY
- Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al
- (2019) Lea C Berkhout et al. ANNALS OF THE RHEUMATIC DISEASES
- The Therapeutic Potential of Nanobodies
- (2019) Ivana Jovčevska et al. BIODRUGS
- HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
- (2019) Aleksejs Sazonovs et al. GASTROENTEROLOGY
- Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches
- (2019) Maria Cristina Petralia et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis
- (2019) Daniela V. Bavaresco et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery
- (2019) Ruben J. Boado et al. Scientific Reports
- Inflammation in psychiatric disorders: what comes first?
- (2018) Moisés E. Bauer et al. Annals of the New York Academy of Sciences
- Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors
- (2018) Timothy Beukelman et al. ANNALS OF THE RHEUMATIC DISEASES
- Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”
- (2018) Isabelle Cludts et al. CYTOKINE
- Lymphotoxin in physiology of lymphoid tissues – Implication for antiviral defense
- (2018) Ekaterina P. Koroleva et al. CYTOKINE
- Intracellular regulation of TNF activity in health and disease
- (2018) Eugene Varfolomeev et al. CYTOKINE
- Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists
- (2018) Rajesh Shah et al. DIGESTIVE DISEASES AND SCIENCES
- Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
- (2018) Renaud Gaujoux et al. GUT
- Etanercept for the treatment of rheumatoid arthritis
- (2018) Sizheng Zhao et al. Immunotherapy
- Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
- (2018) Gregory S. Calip et al. INTERNATIONAL JOURNAL OF CANCER
- Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis
- (2018) Minh Vu Chuong Nguyen et al. JOINT BONE SPINE
- Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far
- (2018) Meghna Jani et al. RHEUMATOLOGY
- Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
- (2018) Norbert Müller SCHIZOPHRENIA BULLETIN
- Peripheral Etanercept Administration Normalizes Behavior, Hippocampal Neurogenesis, and Hippocampal Reelin and GABAA Receptor Expression in a Preclinical Model of Depression
- (2018) Kyle J. Brymer et al. Frontiers in Pharmacology
- The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells
- (2018) Lin-Lin Ye et al. Frontiers in Immunology
- Anti-TNF Therapy in Crohn’s Disease
- (2018) Samuel O. Adegbola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs
- (2018) Arianna Draghi et al. INTERNATIONAL JOURNAL OF CANCER
- Primary and secondary nonresponse to infliximab: mechanisms and countermeasures
- (2017) Uni Wong et al. Expert Opinion on Drug Metabolism & Toxicology
- Lithium + Colchicine
- (2017) John J. Mooney et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
- (2017) Kathryn P. MacPherson et al. NEUROBIOLOGY OF DISEASE
- Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
- (2017) Wan-Ju Lee et al. RHEUMATOLOGY
- Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry
- (2017) Ingrid Becker et al. ARTHRITIS CARE & RESEARCH
- Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting
- (2017) Serena Pastore et al. PEDIATRIC DRUGS
- Infliximab ameliorates AD-associated object recognition memory impairment
- (2016) Dong Hyun Kim et al. BEHAVIOURAL BRAIN RESEARCH
- Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
- (2016) Stefanos Bonovas et al. Expert Opinion On Drug Safety
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder
- (2016) Francesco Benedetti et al. JOURNAL OF AFFECTIVE DISORDERS
- Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?
- (2016) Gionata Fiorino et al. Journal of Crohns & Colitis
- Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
- (2016) Alon D. Levin et al. Journal of Crohns & Colitis
- Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis
- (2016) Y Saka et al. LUPUS
- Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
- (2016) Sara Verazza et al. Pediatric Rheumatology
- Efficacy and safety of TNF-α inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis
- (2016) Wei Liu et al. Scientific Reports
- Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
- (2015) Sarah S. Thomas et al. BIODRUGS
- Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study
- (2015) Joan Calzada-Hernández et al. Pediatric Rheumatology
- Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response
- (2015) Luz M. Canet et al. Pharmacogenetics and Genomics
- State of the art paper Tumor necrosis factor inhibitors – state of knowledge
- (2015) Krzysztof Lis et al. Archives of Medical Science
- Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2014) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
- (2014) David J. Shealy et al. mAbs
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
- (2013) V P Bykerk et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- (2013) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
- (2013) Y Dondelinger et al. CELL DEATH AND DIFFERENTIATION
- Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs
- (2013) Young Ho Lee et al. International Journal of Rheumatic Diseases
- An update on drug–drug interactions with biologics for the treatment of moderate-to-severe psoriasis
- (2013) Rishu Gupta et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions
- (2013) Jose Ramon Maneiro et al. JAMA Internal Medicine
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Microglia and neurodegeneration: The role of systemic inflammation
- (2012) Colm Cunningham GLIA
- Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
- (2012) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
- (2011) M. W. Heijstek et al. ANNALS OF THE RHEUMATIC DISEASES
- COGNITIVE IMPROVEMENT WITH INTRATHECAL ADMINISTRATION OF INFLIXIMAB IN A WOMAN WITH ALZHEIMER'S DISEASE
- (2011) Jian-Quan Shi et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors
- (2011) Andrew J Solomon et al. Multiple Sclerosis Journal
- Research and development of next generation of antibody-based therapeutics
- (2010) Jing Li et al. ACTA PHARMACOLOGICA SINICA
- Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
- (2010) Jian-Quan Shi et al. BRAIN RESEARCH
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
- (2009) G R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab
- (2009) Vicki Oldfield et al. BIODRUGS
- Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis
- (2009) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis
- (2009) Roger Palframan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- TNF-α and its inhibitors in cancer
- (2009) Inès Zidi et al. MEDICAL ONCOLOGY
- Anti-TNF-induced lupus
- (2009) E. L. Williams et al. RHEUMATOLOGY
- MIF in autoimmunity and novel therapeutic approaches
- (2008) Stanislava Stosic-Grujicic et al. AUTOIMMUNITY REVIEWS
- Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
- (2008) Robert S Wallis LANCET INFECTIOUS DISEASES
- The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor expression in the synovium
- (2007) C A Wijbrandts et al. ANNALS OF THE RHEUMATIC DISEASES
- TNF-mediated inflammatory disease
- (2007) JR Bradley JOURNAL OF PATHOLOGY
- Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents
- (2007) Michelle F. Costa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More